Hepatitis B vaccine is a vaccine that prevents hepatitis B, with the first dose recommended within 24 hours of birth followed by two or three more doses, resulting in more than 95 percent protection among healthy people who complete routine immunization. It is produced using recombinant DNA techniques and contains an immunologic adjuvant, and is available both by itself and in combination with other vaccines. The first hepatitis B vaccine, Merck's Heptavax-B, was approved in the United States in 1981, followed by a recombinant version, Recombivax-HB, in 1986; both were developed by Maurice Hilleman and his team. It is on the World Health Organization's List of Essential Medicines.
Facts
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundationhttps://en.wikipedia.org/wiki/Hepatitis_B_vaccine, lead sectionQuote, https://en.wikipedia.org/wiki/Hepatitis_B_vaccine, lead section
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
2. Wikipedia: Hepatitis B Vaccine Online Reference Encyclopedia Article
WikipediaLead sectionQuote, Lead section
The first hepatitis B vaccine (Mercks Heptavax-B) was approved in the United States in 1981.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.
View At A Past Year
Choose a year to see this entry's facts and connections as the atlas records them at that moment: what it held then, what it held instead, and what it had not yet adopted. Choose Present for the current record.